Doctor profile · Federal record
Dr. TATYANA GROYSMAN, D.O.
Dermatology Physician (CMS: DERMATOLOGY) · Dermatopathology Physician · NEW YORK, NY
- NPI 1346477445
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
150 W 55TH ST
NEW YORK, NY 100195586
(212) 991-6490 - Mailing address
-
145 E 32ND ST, 10TH FLOOR
NEW YORK, NY 100166055
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- March 7, 2025
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #270290
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346477445. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
611
Distinct HCPCS
10
Medicare allowed
$36,467
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 231 | 43 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 107 | 85 | $100 | |
17000 |
Destruction of precancer skin growth, 1 growth | 55 | 49 | $57 | |
11102 |
Biopsy of related skin growth, first growth | 42 | 41 | $105 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 42 | 34 | $140 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 31 | 31 | $128 | |
17110 |
Destruction of skin growth, 1-14 growths | 30 | 20 | $125 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | 18 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 26 | 22 | $62 | |
11901 |
Injection into skin growth, more than 7 growths | 19 | 12 | $65 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 3.4× the peer median.Open Payments
Industry payments received
All-time total
$2,096
Transactions
93
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 11 | $500.38 | |
| ABBVIE INC. | 25 | $365.35 | |
| Amgen Inc. | 8 | $198.24 | |
| Arcutis Biotherapeutics, Inc. | 11 | $189.26 | |
| Dermavant Sciences, Inc. | 10 | $177.19 | |
| PFIZER INC. | 9 | $149.73 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $147.13 | |
| Lilly USA, LLC | 3 | $86.26 | |
| Novartis Pharmaceuticals Corporation | 4 | $82.62 | |
| Verrica Pharmaceuticals Inc. | 3 | $55.95 | |
| Incyte Corporation | 2 | $48.97 | |
| LEO Pharma Inc. | 2 | $45.80 | |
| UCB, Inc. | 2 | $34.86 | |
| STRATA Skin Sciences, Inc. | 1 | $14.40 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
219
Patients
128
Total drug cost
$23,946
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 57 | 38 | $1,229 |
| Triamcinolone Acetonide | Generic | 39 | 31 | $550 |
| Fluocinonide | Generic | 25 | 17 | $1,540 |
| Mupirocin | Generic | 23 | 18 | $201 |
| Clobetasol Propionate | Generic | 14 | 13 | $748 |
| Jublia (Efinaconazole) | Brand | 14 | 0 | $17,732 |
| Ammonium Lactate | Generic | 12 | 0 | $337 |
| Hydrocortisone | Generic | 12 | 11 | $130 |
| Minoxidil | Generic | 12 | 0 | $182 |
| Metronidazole | Generic | 11 | 0 | $1,297 |